Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,511,320 papers from all fields of science
Search
Sign In
Create Free Account
ImmunoCyt
A combination of 3 fluorescent-tagged monoclonal antibodies. Recently licensed for screening of bladder cancer recurrence by urine test.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Bladder cancer : diagnosis and management . Guideline Developer ( s )
2017
Corpus ID: 31474684
Description of Implementation Strategy Implementation tools and resources to help you put the guideline into practice are also…
Expand
2016
2016
Evaluation der prognostischen Wertigkeit der Urinzytologie und der Urinmarker UroVysion, ImmunoCyt/uCyt+ und NMP22 ELISA in der Rezidivdiagnostik des Urothelkarzinoms
Petra Soliman
2016
Corpus ID: 79533133
2013
2013
Significance of urinary telomerase,nuclear matrix protein 22(NMP22) and ImmunoCyt in the early diagnosis of bladder transitional cell carcinoma
Cui Guo-xing
2013
Corpus ID: 75241564
Objective To evaluate the clinical significance of urinary telomerase,nuclear matrix protein 22(NMP22) and ImmunoCyt in the early…
Expand
Review
2008
Review
2008
Bladder Cancer Urinary Markers in Bladder Cancer
O. Vrooman
,
J. Witjes
2008
Corpus ID: 42928106
Objectives: Many markers for the detection of bladder cancers have been tested. Almost all urinary markers reported are better…
Expand
2003
2003
Role of ImmunoCyt in the early diagnosis of bladder cancer
Shen Hai-b
2003
Corpus ID: 76293275
Objective To evaluate the effect of ImmunoCyt on the early diagnosis of bladder cancer by comparing the result of cystoscopy with…
Expand